Healthcare -
Biotechnology - NASDAQ - US
$ 0.47
-0.844 %
$ 27.3 M
Market Cap
-0.28
P/E
BCAB - CAPITAL EXPENDITURES
Capital Expenditures BCAB - BioAtla, Inc.
-98 K
LAST VALUE
67.43%
2 YEAR CAGR
37.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR